Business

Timothy P. Walbert Joins Patient Square Capital as a Senior Advisor

MENLO PARK, Calif., May 06, 2026--Patient Square Capital, a leading health care investment firm, today announced that Timothy P. Walbert has joined the firm as a Senior Advisor.

articleAbbott LaboratoriesMay 6, 20262/company/abbott-laboratories/news/timothy-p-walbert-joins-patient-square-capital-as-a-senior-advisor
Timothy P. Walbert Joins Patient Square Capital as a Senior Advisor

About this update from Abbott Laboratories

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/c44eecb5a6cbddeed071abbc120cde99"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/sr_f8WvPijqeJvBTvrZRlA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/c44eecb5a6cbddeed071abbc120cde99","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/LV3TVLbae9Bszf1KuwDWlg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/c44eecb5a6cbddeed071abbc120cde99","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MENLO PARK, Calif., May 06, 2026--(BUSINESS WIRE)--Patient Square Capital, a leading health care investment firm, today announced that Timothy P. Walbert has joined the firm as a Senior Advisor.","length":194,"tagName":"p"},{"type":"text","content":"Mr. Walbert brings more than three decades of biopharmaceutical leadership experience and currently serves as Managing Partner of HRZN Partners LLC and a Senior Advisor to Amgen. Most recently, he was Chairman, President, and Chief Executive Officer of Horizon Therapeutics, which he grew to approximately $4 billion in annual sales prior to its $28.3 billion acquisition by Amgen in 2023; earlier, he led IDM Pharma Inc. through its acquisition by Takeda and held senior roles at Abbott (now AbbVie), where he led the global launch of HUMIRA®, as well as at G.D. Searle & Company, Merck & Co., and Wyeth.","length":613,"tagName":"p"},{"type":"text","content":""Patient Square Capital has built a highly differentiated platform and a strong record of partnering with management teams to create enduring value in health care," said Tim Walbert. "I’m pleased to join the firm as a Senior Advisor and look forward to contributing my experience in support of the team and its portfolio companies as they advance innovations that improve patient outcomes."","length":410,"tagName":"p"},{"type":"text","content":""Tim is an extremely accomplished leader and business builder with a proven history of delivering impactful therapies to patients and creating significant long-term value," said Jim Momtazee, Managing Partner of Patient Square Capital. "We have k...

More updates from Abbott Laboratories

Tim WalbertSenior AdvisorHorizon TherapeuticsTimothy P. WalbertSucampo Pharmaceuticalsportfolio companiesWalbertMirum Pharmaceuticals